Home » Authors » Trista Morrison

Articles by Trista Morrison

Elixir Raises $46M Series C For Metabolic Disease Trials

Nov. 29, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Sofinnova Closes $375M Fund To Support Spinouts

Nov. 15, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...